Objectives To evaluate in fetal aneuploidy screening the desirability of using Fetal Medicine Foundation (FMF) normal medians of nuchal translucency thickness (NT) measurements or performerspecific medians, and whether the NT measurements should be expressed as Delta-NT or Log NT-MoM values. Settings First trimester-combined screening programme in a low risk population in Flanders, Belgium (Algemeen Medisch Laboratorium, Antwerp). Methods Pregnancies unaffected by trisomy 21 (T21) were screened by FMF-trained or other ultrasonographers. Performer-specific NT medians were established for FMF-trained and other ultrasonographers. NCSS Statistical Software was used to establish probability plots for Log NT-MoM and Delta-NT values, relative to performer-specific references or to the FMF-reference. Results A total of 16,096 pregnancies were evaluated. Six FMF-trainees and five other ultrasonographers each performed between 83 and 658 NT measurements. For the FMF-trainees, FMF-specific NT-MoM medians were close to one at a crown-rump length (CRL) between 50 and 80 mm, whereas the population-specific NT-MoM medians of the other ultrasonographers were close to one at a CRL between 40 and 80 mm. Performer-specific Delta-NT values fitted a Gaussian distribution between the 5th and 90th percentiles, while for the Log NT-MoM values this was between the 10th and 95th percentiles. Conclusion We conclude that (i) the use of screening would benefit from performer-specific NTmedians based on Log NT-MoM values; (ii) the use of Log NT-MoM values is marginally better than the use of delta-NT MoMs; and (iii) NT measurements are valid at about 10 weeks (crown-rump length 40-45 mm) as well as at 11-13 weeks.
INTRODUCTION
I n fetal aneuploidy screening today, mathematical algorithms are used to calculate an individual's risk for fetal chromosomal abnormalities using parameters derived from maternal serum and/or obtained by ultrasound. As the measured values for every parameter vary throughout gestation, the observed values are expressed as a function of the median at the same gestation, either as a multiple (multiples of the median [MoM]) 1 or as a difference (Delta). 2 For fetal nuchal translucency thickness (NT) measurements, the measured values are expressed in relation to the median values at the corresponding fetal crown-rump lengths (CRL). The CRL-related medians can be derived from a standard reference curve, such as the one published by the Fetal Medicine Foundation (FMF), 3 or can be performer-, centre-or population-specific. 4, 5 In the fetal aneuploidy screening programme organized by the Algemeen Medisch Laboratorium (AML) in Antwerp, Belgium, NT-related screening was introduced in 1999. 6 In this programme, NT was implemented into first or second trimester screening algorithms, expressed as logarithmic NT-MoM values (Log NT-MoM) in relation to the FMF reference range. We reported the results of an audit on the methodology of NT measurement in this programme by comparing the observed Delta-NT values with those from the standard FMF curve. 7 This audit showed a systematic underestimation of the NT measurements by the ultrasonographers, who were not enlisted as FMF trainees at the official FMF website, compared with the measurements of the ultrasonographers who were on this list.
In the present study, we compare the performer-specific CRL-related NT medians from the FMF-trainees with those from the other ultrasonographers. We also evaluate the effect on the NT distribution curves of introducing population-or performer-specific median NT values for calculation of NT-MoM or Delta-NT values. Our methods of data collection and risk calculation are reported elsewhere. 7 According to outcome of pregnancy, all data were grouped as follows: trisomy 21 (T21)-affected pregnancies; pregnancies with fetal chromosomal anomalies different from T21; pregnancies with fetal loss of unknown genetic constitution; and unaffected pregnancies. In this study, only unaffected pregnancies were considered.
MATERIALS AND METHODS
A total of 2700 NT/CRL measurements were mailed to FMF. From these data, CRL-related NT-MoM were mailed back to us, which we used to establish the FMF reference curve of gestation-related NT values. We also received from FMF the NT-MoM-values at CRL measurements below 45 mm, but a note was added to consider the FMF reference range only at CRL values between 45 and 85 mm. We also established a population-specific reference curve of CRLrelated median NT values from all unaffected pregnancies screened by 258 ultrasonographers who were not enlisted at the FMF website (AML reference). Finally, we established a performer-specific curve of CRL-related NT medians for every individual FMF-trained ultrasonographer, and for the five non-FMF trainees who performed the most numerous screening tests in the AML screening programme. We used both the FMF medians, the AML medians and the performer-specific medians to calculate values of Log NT-MoM and Delta-NT. NCSS Statistical Software (East-Kaysville, Utah, USA) was used to establish probability plots for all NT measurements, expressed as Log NT-MoM or Delta-NT relative to the FMF reference or to AML-or performerspecific reference values. All distribution curves were plotted graphically.
RESULTS
We evaluated NT measurements from a total of 16,096 unaffected pregnancies. These measurements were performed by a total of 264 ultrasonographers, of whom six were enlisted at the FMF website between 1 January 2003 and 1 May 2004. FMF trainees A-F performed 600, 352, 144, 140, 194 and 83 NT measurements, respectively. The five most active non-FMF trainee ultrasonographers in the AML screening programme (V-Z) performed 483, 658, 518, 262 and 361 NT measurements, respectively. The NT measurements of all other ultrasonographers were not evaluated individually. Figure 1 shows the plot of CRL-related NT measurements of the group of FMF trainees and of the group of all other ultrasonographers, expressed as NT-MoM. The FMF trainees have systematically higher NT medians compared with the other ultrasonographers. Figure 1a shows the NT measurements expressed in relation to the FMF reference range, whereas Figure 1b shows the same measurements expressed in relation to the population-specific reference range. In Figure 1a , the median NT-MoM of the FMF trainees is around one at a CRL between 50 and 80 mm, but is above one at lower CRL values. In Figure 1b , the median NT-MoM is around one at a CRL between 40 and 80 mm. Figure 2 shows the CRL-related NT medians (in mm on a log scale) for every individual FMF trainee ( Figure 2b ) and for five other ultrasonographers (Figure 2a ). As is shown, all performer-specific curves are different, both in the FMF trainee group and in the group of other ultrasonographers. However, the inter-observer variation is less in the FMF trainee group compared with the other ultrasonographers. The curves of four of the non-FMF trainees are relatively close to those of the FMF trainees, whereas non-FMF trainee Y (open triangles) has systematically very low NT measurements.
Probability plots of NT measurements are shown in Figure 3 , either expressed as performer-specific Delta-NT ( Figure 3a) or Log NT-MoM ( Figure 3b ). As is shown, the plot for Delta-NT is linear between percentile (P) 5 and P90, whereas this is between P10 and P95 for Log NT-MoM values. Thus, in the upper range of NT measurement, the Log NT-MoM plot fits a Gaussian distribution better than the Delta-NT plot.
DISCUSSION
In the fetal aneuploidy screening programme organized by AML, NT measurements were introduced as a screening parameter in 1999, first in combination with second trimester triple serum parameters 6 and later also with first trimester serum screening. 8 In these algorithms, NT measurements are expressed as Log NT-MoM, relative to a standard reference range established by FMF. 3 Our audit on NT measurements, as used in our programme, showed a systematic underestimation of NT measurements from a group of ultrasonographers not enlisted as FMF trainees at the FMF website, compared with the measurements of FMF trainees. 7 As a consequence, Figure 1b shows the same data calculated in relation to the AML population-specific medians our first trimester combined screening algorithm was less efficient at detecting T21-affected pregnancies compared with single-centre studies using FMF scanning criteria. 8 Our results, however, were very close to those of multicentre studies using FMF scanning criteria or using group-or performer-specific reference values for NT. 8 We have been investigating several pathways to improve the overall screening results of our programme. One of these measures was an attempt to increase the number of FMF trainees in the programme. 9 Despite many efforts, the number of FMF trainees in Flanders enlisted at the FMF website has not yet increased, and many obstetricians do not intend to participate in the FMF programme for first trimester ultrasound screening and audit. In this study, we evaluated whether an improvement of screening performance could be expected from the introduction of performer-specific instead of FMF-specific NT medians and from the use of Delta-NT instead of Log NT-MoM values. Figure 1 shows that the group-specific CRL-related NT medians of non-FMF trainee ultrasonographers are systematically lower than those of FMF trainees, which confirms our reported observation. 7 This may be the result of the FMF recommendation to use the largest NT value measured for each pregnancy. 3 Much of the inter-individual variation can be avoided by using ultrasonographer-specific Delta-NT or Log NT-MoM values. Figure 1 also shows that FMF-specific NT medians from the FMF trainees are around one at a CRL between 50 and 80 mm, and that the population-specific NT medians of the other ultrasonographers are around one at a CRL between 40 and 80 mm. This may be the result of our use of unvalidated FMF reference values at CRL o45 mm: as discussed above, the FMF provided Log NT-MoM values at a CRL o45 mm, but recommended that the data should not be considered valid as the FMF has established its reference range at CRL between 45 and 85 mm. 3 The current fetal aneuploidy screening algorithm distributed by FMF does not allow the implementation of NT values measured before 11 weeks of gestation, due to which the gestational window for risk calculations is limited to 11-14 weeks. On the other hand, our observation may also be an illustration of the difficulty of measuring NT correctly at early stages of pregnancy. Zoppi et al. 10 recently reported that the accuracy of NT measurements, according to FMF criteria, improved with advancing gestation. We already reported that in our database, 12.4% of NT measurements were performed at CRL o45 mm. 7 Our data illustrate that the use of a population-, group-or performer-specific reference range allows the use of NT as a screening parameter for fetal aneuploidy before 11 weeks of gestation, which expands the gestational window for first trimester ultrasound screening for chromosomal abnormalities from 11-14 weeks to approximately 10-14 weeks.
The relevance of using performer-specific NT medians for fetal aneuploidy screening is illustrated in Figures 2a and 2b . For all ultrasonographers, the curves of CRL-related NT medians are different, both in the FMF trainee group and in the group of other ultrasonographers. The inter-individual variation between these curves is less for the FMF trainee ultrasonographers than for the others because of ultrasonographer Y. As is shown, the curves of four of five non-FMFtrainees are relatively close to the curves of the FMF trainees, which indicate that some ultrasonographers may achieve acceptable NT measurements even without official accreditation by the FMF. Our results may perhaps be biased by our choice of the non-FMF trainee ultrasonographers with the most numerous NT measurements in the AML screening programme. These ultrasonographers perform ultrasound screening on a regular basis and are likely to have developed a specific method for ultrasonic measurement of NT. This may not be true for ultrasonographers who perform a lower number of ultrasound scans. The curve of non-FMF trainee ultrasonographer Y illustrates that some ultrasonographers may have NT measurements which deviate from the FMF criteria and from those of other ultrasonographers. This is likely to be the result of a lack of methodology, and training into ultrasound screening is recommendable for this person. One of the most important effects of ultrasound training is a reduction of inter-and intra-observer variability or standard deviation of NT measurement. 11 Appropriate estimates of risk of Down's syndrome can be calculated if it is reasonable to assume the NT measurements are sampled from a Gaussian distribution. In Figure 3 , we examine the Gaussian assumption for the Log NT-MoM transformation and for the Delta-NT transformation. It is shown that the Log NT-MoM transformation fits a Gaussian distribution better above the 10th percentile, which is of relevance in screening given that high NT values contribute to an increased risk of Down's syndrome. Thus, we think that Log NT-MoMs should be used in our screening algorithm.
We conclude from this study that (i) the use of screening would benefit from performer-specific NT medians based on Log NT-MoM values; (ii) the use of Log NT-MoM values is similar to or marginally better than the use of Delta-NT; and (iii) NT measurements are valid at about 10 weeks (CRL 40-45 mm) as well as at 11-14 weeks.
